View this article online at www.insightplus.mja.com.au
Pancreatic cancer must be recognised as a national health priority, supported by long-term investment in research, clinical innovation, workforce capability, and equitable access to care.
The launch of the National Cancer Data Framework marks a significant milestone in Australian cancer care, setting a new standard for how health data is integrated and used across the sector. By ensuring cancer data is collected and reported in a nationally consistent manner, the sector will be able to answer key questions about cancer control, measure adherence to optimal care pathways and identify disparities in cancer care.
A TGA approved drug that prevents kidney failure in thyroid cancer survivors remains inaccessible
As pancreas cancer rates rise, Professor Steve Robson reflects on his personal ties to the disease, and his hopes for future screening and treatment.
The launch of Australia’s National Lung Cancer Screening Program (NLCSP) is a step forward in preventive healthcare — but screening thousands of high-risk Australians with low-dose CT scans will inevitably uncover a far greater number of people with undiagnosed chronic respiratory disease, particularly chronic obstructive pulmonary disease (COPD).
Bowel cancer rates are rising in young people, and researchers are working tirelessly to find out why, writes Dr Lisa Mielke.
Cancer is traditionally known as a disease affecting mostly older people.
Rising incidence of gastro–oesophageal cancers
InSight+ spoke with Monash University researchers about a new breakthrough they say could revolutionise immunotherapy for cancer.
